Necroptosis as a consequence of photodynamic therapy in tumor cells
Lasers in Medical Science · 2024
DOI: 10.1007/s10103-024-04218-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lasers in Medical Science, 2024. Verfasst von Álvaro Carneiro de Souza und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Rua José Lourenço Khelmer - s/n, Campus Universit…. Hauptthemen laut MEDLINE: Photochemotherapy, Necroptosis, Neoplasms, Photosensitizing Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is an alternative to cancer treatment, demonstrating selectivity and significant cytotoxicity on malignant tissues. Such therapy involves two nontoxic components: photosensitizer (PS) and non-ionizing radiation. In optimal dosage combinations, PDT causes cellular and tissue effects by oxygen-dependent processes, leading tumor cells to regulated cell death pathways. Regulated necrosis, called necroptosis, can be triggered by PDT and is characterized by caspase-8 inhibition and RIPK1, RIPK3, and MLKL activities, leading to plasma membrane pores formation with subsequent cellular content release into the extracellular space. For this review, studies accessed by PubMed describing the relation between necroptosis and PDT were summarized. The results showed that PDT can trigger necroptosis mechanisms in different tumor cells. Moreover, a mix of different cell death types can co-occur. It is also important to highlight that necroptosis triggered by PDT is related to damage-associated molecular patterns (DAMPs) release, involving immunogenic cell death and vaccination. The cell death response is directly related to the photosensitizer chemical characteristics, concentration, incubation time, cellular location, and irradiation parameters. The synergism among all cell death types is an excellent advantage for avowing tumor resistance mechanisms and developing new solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Rua José Lourenço Khelmer - s/n, Campus Universitário, São Pedro, Juiz de Fora, Minas Gerais, 36036900, Brazil. alvaro_…
- Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Boulevard Vinte e Oito de Setembro, 87, fundos, Vila Isabel, Rio de Janeiro, 20551030, Braz…
- Departamento de Ciências Fisiológicas, Instituto Biomédico, Universidade Federal do Estado do Rio de Janeiro, Rua Frei Caneca, 94, Rio de Janeiro, 20211040, Brazil.
- Centro de Ciências da Saúde, Centro Universitário Serra dos Órgãos, Avenida Alberto Torres, 111, Teresópolis, Rio de Janeiro, 25964004, Brazil.
- Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Rua José Lourenço Khelmer - s/n, Campus Universitário, São Pedro, Juiz de Fora, Minas Gerais, 36036900, Brazil.
ORCID-Profile: André Luiz Mencalha, Adenilson de Souza da Fonseca, Flávia de Paoli
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
de Souza, Á. C., Mencalha, A. L., Fonseca, A. S. D., & de Paoli, F. (2024). Necroptosis as a consequence of photodynamic therapy in tumor cells. Lasers in Medical Science. https://doi.org/10.1007/s10103-024-04218-5
Vancouver
de Souza ÁC, Mencalha AL, Fonseca ASD, de Paoli F. Necroptosis as a consequence of photodynamic therapy in tumor cells. Lasers in Medical Science. 2024. doi:10.1007/s10103-024-04218-5
BibTeX
@article{deSouza2024,
author = {de Souza, Álvaro Carneiro and Mencalha, André Luiz and Fonseca, Adenilson de Souza da and de Paoli, Flávia},
title = {Necroptosis as a consequence of photodynamic therapy in tumor cells},
journal = {Lasers in Medical Science},
year = {2024},
doi = {10.1007/s10103-024-04218-5}
}
EUVIMED